​

Kyverna Therapeutics Ownership | Who Owns Kyverna Therapeutics?

OverviewForecastFinancialsChart

Kyverna Therapeutics Ownership Summary

Kyverna Therapeutics is owned by 59.72% institutional investors, 2.26% insiders, and 38.02% retail investors. Corton capital is the largest institutional shareholder, holding 0% of KYTX shares.

KYTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKyverna Therapeutics59.72%2.26%38.02%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Corton capital---
Verition fund management---
Simplex trading---
Rock springs capital management lp---
Us bancorp \de\---
Ameriprise financial---
Integral health asset management---
Squarepoint ops---
Alyeska investment group---
Deutsche bank ag\---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Corton capital---
Verition fund management---
Simplex trading---
Rock springs capital management lp---
Us bancorp \de\---
Ameriprise financial---
Integral health asset management---
Squarepoint ops---
Alyeska investment group---
Deutsche bank ag\---

Top Buyers

HolderShares% AssetsChange
Simplex trading---3.77K
Deutsche bank ag\---4.17K
Us bancorp \de\---4.60K
Squarepoint ops---11.49K
Corton capital---12.10K

Top Sellers

HolderShares% AssetsChange
Integral health asset management---350.00K
Ameriprise financial---190.38K
Rock springs capital management lp---178.96K
Sphera funds management---118.76K
Verition fund management---90.23K

Sold Out

HolderChange
Simplex trading-3.77K
Deutsche bank ag\-4.17K
Us bancorp \de\-4.60K
Squarepoint ops-11.49K
Corton capital-12.10K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202588-1.12%25,809,724-9.40%591.37%41-26.79%2592.31%
Dec 31, 202490-4.26%28,867,9802.72%661.58%5711.76%13-38.10%
Sep 30, 2024944.44%28,104,372-12.02%651.19%51-19.05%2190.91%
Jun 30, 202490-2.17%31,942,9114.22%740.44%63-29.21%11-
Mar 31, 202492-30,649,915-129-89---

Recent Insider Transactions

DateNameRoleActivityValue
Feb 12, 2024GILEAD SCIENCES, INC.-Buy$20.02M

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q11-
2022 Q3--

KYTX Ownership FAQ

Who Owns Kyverna Therapeutics?

Kyverna Therapeutics shareholders are primarily institutional investors at 59.72%, followed by 2.26% insiders and 38.02% retail investors. The average institutional ownership in Kyverna Therapeutics's industry, Biotech Stocks , is 63.96%, which Kyverna Therapeutics falls below.

Who owns the most shares of Kyverna Therapeutics?

Kyverna Therapeutics’s largest shareholders are Corton capital (0 shares, 0%), Verition fund management (0 shares, 0%), and Simplex trading (0 shares, 0%). Together, they hold 0% of Kyverna Therapeutics’s total shares outstanding.

Does Blackrock own Kyverna Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Kyverna Therapeutics.

Who is Kyverna Therapeutics’s biggest shareholder by percentage of total assets invested?

Corton capital is Kyverna Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Kyverna Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools